Progressive Care (RXMD) Conference Call.
Progressive Care Announces Shareholder Conference Call and Business Update on November 14, 2022
MIAMI, FL, Nov. 08, 2022...
Corona Craziness Continues. Organicell (BPSR) Gains 10-fold or 1000%, in Six Weeks.
Too bad we don't trade for a living! We don't even use real-time quotes, LOL. $0.02 to $0.27, from Easter - what...
Surna Cultivation Technologies Signs Contract for New Addition to Product Portfolio
Converted Air Sanitization Product Partnership to Customer Contract in Under Thirty Days
Louisville, Colorado, April 05, 2022 (GLOBE NEWSWIRE) -- CEA Industries...
Diabasens® to Launch in Europe. Innovus (INNV).
"The product will be launched initially in France, the United Kingdom, Italy, Germany and Spain through our Pan-European Amazon® store, followed by...
Fortress Bio (FBIO) Inches Closer to $3.00 on Major News.
Fortress Bio (FBIO) Inches Closer to $3.00 on Major News.
Citius Pharma (CTXR) Inches Closer to the Next Phase...
Revive Therapeutics Gains 25% on Positive FDA Comments.
The Company stated yesterday that it "has received positive comments from the FDA in regard to the Company’s request to determine and...
Smart For Life (SMFL) $0.37 Announces Initiation of Equity Analyst Coverage by Dawson James...
Initiates with “Buy” recommendation and $8 price target.
MIAMI, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Smart for Life,...
Telehealth: CB Scientific (CBSC) Acquires Prevent Health Care International Corp.
CB Scientific, Inc. (CBSC) Announces Completion of Asset Purchase Agreement and Commencement of Its ECG Monitoring Business.
SEC Charges Microcap Fraud Scheme Participants Attempting to Capitalize on the COVID-19 Pandemic.
FOR IMMEDIATE RELEASE2020-131
Washington D.C., June 11, 2020 —
The Securities and...
Are Psychedelics the New Prozac?
Amidst a national epidemic of opioid abuse, and suicides the need for new therapeutics has gained greater urgency. In it's first step to...
Latest article
We’re in Tampa for the Kentucky Derby.
GeoVax (GOVX), Sees a Little Volume.
Normally, we get a little nervous when one of the companies we...
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
